Canada
· Delayed Price · Currency is CAD Filament Health Statistics
Total Valuation
Filament Health has a market cap or net worth of CAD 6.34 million. The enterprise value is 6.43 million.
| Market Cap | 6.34M |
| Enterprise Value | 6.43M |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 261.79M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +27.08% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 92.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.02 |
| PB Ratio | 6.51 |
| P/TBV Ratio | 12.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.31 |
| EV / Sales | 15.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.05 |
Financial Position
The company has a current ratio of 0.16, with a Debt / Equity ratio of 0.23.
| Current Ratio | 0.16 |
| Quick Ratio | 0.15 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | -27.31 |
Financial Efficiency
Return on equity (ROE) is -347.26% and return on invested capital (ROIC) is -104.08%.
| Return on Equity (ROE) | -347.26% |
| Return on Assets (ROA) | -64.32% |
| Return on Invested Capital (ROIC) | -104.08% |
| Return on Capital Employed (ROCE) | -363.23% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 13 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.64% in the last 52 weeks. The beta is 1.02, so Filament Health's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | -63.64% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 47.52 |
| Average Volume (20 Days) | 16,937,072 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Filament Health had revenue of CAD 422,226 and -4.91 million in losses. Loss per share was -0.02.
| Revenue | 422,226 |
| Gross Profit | 422,226 |
| Operating Income | -3.81M |
| Pretax Income | -4.91M |
| Net Income | -4.91M |
| EBITDA | -3.73M |
| EBIT | -3.81M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 130,441 in cash and 225,460 in debt, giving a net cash position of -95,019.
| Cash & Cash Equivalents | 130,441 |
| Total Debt | 225,460 |
| Net Cash | -95,019 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 974,377 |
| Book Value Per Share | 0.00 |
| Working Capital | -1.57M |
Cash Flow
In the last 12 months, operating cash flow was -1.56 million and capital expenditures -29,254, giving a free cash flow of -1.59 million.
| Operating Cash Flow | -1.56M |
| Capital Expenditures | -29,254 |
| Free Cash Flow | -1.59M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -901.33% |
| Pretax Margin | -1,162.92% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Filament Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.08% |
| Shareholder Yield | -27.08% |
| Earnings Yield | -77.42% |
| FCF Yield | -25.08% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |